These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30941131)

  • 1. The Association Between Vitamin D and Multiple Sclerosis Risk: 1,25(OH)
    Lu M; McComish BJ; Burdon KP; Taylor BV; Körner H
    Front Immunol; 2019; 10():488. PubMed ID: 30941131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes.
    Seuter S; Pehkonen P; Heikkinen S; Carlberg C
    Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular network of chromatin immunoprecipitation followed by deep sequencing-based vitamin D receptor target genes.
    Satoh J; Tabunoki H
    Mult Scler; 2013 Jul; 19(8):1035-45. PubMed ID: 23401126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of risk genes linked to vitamin D receptor super-enhancer regions and their association with phenotype severity in multiple sclerosis.
    Orton SM; Sangha A; Gupta M; Martens K; Metz LM; de Koning APJ; Pfeffer G
    Front Neurol; 2022; 13():1064008. PubMed ID: 36644209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D receptor binding, chromatin states and association with multiple sclerosis.
    Disanto G; Sandve GK; Berlanga-Taylor AJ; Ragnedda G; Morahan JM; Watson CT; Giovannoni G; Ebers GC; Ramagopalan SV
    Hum Mol Genet; 2012 Aug; 21(16):3575-86. PubMed ID: 22595971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular endocrinology of vitamin D on the epigenome level.
    Carlberg C
    Mol Cell Endocrinol; 2017 Sep; 453():14-21. PubMed ID: 28315703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence supports a causal association between allele-specific vitamin D receptor binding and multiple sclerosis among Europeans.
    Adams C; Manouchehrinia A; Quach HL; Quach DL; Olsson T; Kockum I; Schaefer C; Ponting CP; Alfredsson L; Barcellos LF
    Proc Natl Acad Sci U S A; 2024 Feb; 121(8):e2302259121. PubMed ID: 38346204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of Enhancer-mediated Hormonal Control of Vitamin D Receptor Gene Expression in Target Cells.
    Lee SM; Meyer MB; Benkusky NA; O'Brien CA; Pike JW
    J Biol Chem; 2015 Dec; 290(51):30573-86. PubMed ID: 26504088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes.
    Warwick T; Schulz MH; Günther S; Gilsbach R; Neme A; Carlberg C; Brandes RP; Seuter S
    Sci Rep; 2021 Mar; 11(1):6518. PubMed ID: 33753848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic Effects of the Vitamin D Receptor: Potentially the Link between Vitamin D, Immune Cells, and Multiple Sclerosis.
    Lu M; Taylor BV; Körner H
    Front Immunol; 2018; 9():477. PubMed ID: 29593729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
    Zella LA; Kim S; Shevde NK; Pike JW
    Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association of Vitamin D Receptor Polymorphisms with Multiple Sclerosis in a Case-Control Study from Kuwait.
    Al-Temaimi RA; Al-Enezi A; Al-Serri A; Alroughani R; Al-Mulla F
    PLoS One; 2015; 10(11):e0142265. PubMed ID: 26540116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ifng gene is essential for Vdr gene expression and vitamin D₃-mediated reduction of the pathogenic T cell burden in the central nervous system in experimental autoimmune encephalomyelitis, a multiple sclerosis model.
    Spanier JA; Nashold FE; Olson JK; Hayes CE
    J Immunol; 2012 Sep; 189(6):3188-97. PubMed ID: 22896638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis.
    Smolders J; Damoiseaux J; Menheere P; Tervaert JW; Hupperts R
    Ann N Y Acad Sci; 2009 Sep; 1173():515-20. PubMed ID: 19758194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multiple sclerosis-associated regulatory variant rs10877013 affects expression of CYP27B1 and VDR under inflammatory or vitamin D stimuli.
    Karaky M; Alcina A; Fedetz M; Barrionuevo C; Potenciano V; Delgado C; Izquierdo G; Matesanz F
    Mult Scler; 2016 Jul; 22(8):999-1006. PubMed ID: 26466946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D and Genetic Susceptibility to Multiple Sclerosis.
    Scazzone C; Agnello L; Bivona G; Lo Sasso B; Ciaccio M
    Biochem Genet; 2021 Feb; 59(1):1-30. PubMed ID: 33159645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians.
    Orton SM; Ramagopalan SV; Para AE; Lincoln MR; Handunnetthi L; Chao MJ; Morahan J; Morrison KM; Sadovnick AD; Ebers GC
    J Neurol Sci; 2011 Jun; 305(1-2):116-20. PubMed ID: 21440908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D receptor biochemical and genetic profiling and HLA-class II genotyping among Lebanese with multiple sclerosis - A pilot study.
    Yamout B; Karaky NM; Mahfouz RAR; Jaber F; Estaitieh N; Shamaa D; Abbas F; Hoteit R; Daher RT
    J Neuroimmunol; 2016 Apr; 293():59-64. PubMed ID: 27049563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D receptor polymorphisms and 25-hydroxyvitamin D in a group of Sicilian multiple sclerosis patients.
    Agnello L; Scazzone C; Ragonese P; Salemi G; Lo Sasso B; Schillaci R; Musso G; Bellia C; Ciaccio M
    Neurol Sci; 2016 Feb; 37(2):261-7. PubMed ID: 26506927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.